Global Health Headlines: Disruptive Developments and Key Cases

This summary provides the latest updates in health news, including HIV cases from organ transplants in Brazil, Sanofi's business stake sale, and FDA's stance on Eli Lilly's drug compounding. Other highlights include Pfizer's new drug approval, CVS's strategic shift, and discoveries by Dutch authorities.

In a startling revelation, six Brazilian transplant patients contracted HIV from infected organs, prompting rigorous investigations and suspension of the responsible laboratory. Brazilian health authorities emphasize the necessity of robust testing protocols in organ transplants.

Meanwhile, in a significant corporate move, French pharmaceutical giant Sanofi is negotiating the sale of a 50% stake in its Opella consumer health business to Clayton Dubilier & Rice, underscoring an estimated 15 billion euros deal.

In regulatory news, the U.S. FDA is reassessing its decision to restrict compounded versions of Eli Lilly's popular weight loss drugs, which could offer affordable options to patients amid potential ingredient shortages.

(With inputs from agencies.)